Related coverage linked through entity extraction aliases.
Apr 23, 2026
UK Research and Innovation has announced major changes to grant funding, with pauses and cuts affecting medical, biological and physical research. The uncertainty has raised concern over curiosity-driven research, staffing and the system’s tolerance for failure.
Mar 18, 2026
Proteolysis-targeting chimeras (PROTACs) are advancing from experimental to clinical-stage cancer therapies, with first candidates entering Phase III trials. The technology degrades target proteins rather than blocking them, offering new options for previously undruggable targets.
Feb 18, 2026
Researchers have identified how the MYC protein helps pancreatic cancer evade immune detection, while a separate team discovered methods to permanently switch off cancer genes in leukemia through epigenetic therapy targeting Menin and DOT1L proteins.
Feb 13, 2026
An international research team has identified antibody 007, which targets HIV-1's V3 glycan site without depending on sugar structures the virus frequently alters, remaining effective against resistant variants and enhancing combination therapies.
